PYRIMETHAMINE LEUCOVORIN capsule

Krajina: Spojené štáty

Jazyk: angličtina

Zdroj: NLM (National Library of Medicine)

Aktívna zložka:

PYRIMETHAMINE (UNII: Z3614QOX8W) (PYRIMETHAMINE - UNII:Z3614QOX8W), LEUCOVORIN CALCIUM (UNII: RPR1R4C0P4) (LEUCOVORIN - UNII:Q573I9DVLP)

Dostupné z:

South Coast Specialty Compounding, Inc. d/b/a Park Compounding

Spôsob podávania:

ORAL

Typ predpisu:

PRESCRIPTION DRUG

Stav Autorizácia:

unapproved drug other

Súhrn charakteristických

PYRIMETHAMINE LEUCOVORIN- PYRIMETHAMINE LEUCOVORIN CAPSULE
SOUTH COAST SPECIALTY COMPOUNDING, INC. D/B/A PARK COMPOUNDING
_Disclaimer: This drug has not been found by FDA to be safe and
effective, and this labeling has not been_
_approved by FDA. For further information about unapproved drugs,
click here._
----------
PYRIMETHAMINE LEUCOVORIN (50MG-25MG)
PYRIMETHAMINE LEUCOVORIN (50MG-25MG)
PYRIMETHAMINE LEUCOVORIN
pyrimethamine leucovorin capsule
PRODUCT INFORMATION
PRODUCT T YPE
HUMAN PRESCRIPTION DRUG
ITE M CODE (SOURCE )
NDC:70 26 0 -48 0
ROUTE OF ADMINISTRATION
ORAL
ACTIVE INGREDIENT/ACTIVE MOIETY
INGREDIENT NAME
BASIS OF STRENGTH
STRE NG TH
PYRIMETHAMINE (UNII: Z36 14QOX8 W) (PYRIMETHAMINE - UNII:Z36 14QOX8 W)
PYRIMETHAMINE
50 mg
LEUCO VO RIN CALCIUM (UNII: RPR1R4C0 P4) (LEUCOVORIN - UNII:Q573I9
DVLP)
LEUCOVORIN
25 mg
INACTIVE INGREDIENTS
INGREDIENT NAME
STRE NG TH
CELLULO SE, MICRO CRYSTALLINE (UNII: OP1R32D6 1U)
6 5 mg
PRODUCT CHARACTERISTICS
COLOR
o ra nge
S CORE
no sco re
South Coast Specialty Compounding, Inc. d/b/a Park Compounding
S HAP E
c a psule
S IZ E
15mm
FLAVOR
IMPRINT CODE
CONTAINS
PACKAG ING
#
ITEM CODE
PACKAGE DESCRIPTION
MARKETING START DATE
MARKETING END DATE
1
NDC:70 26 0 -48 0 -0 1
10 0 in 1 BOTTLE; Type 0 : No t a Co mbinatio n Pro duct
MARKETING INFORMATION
MARKE TING CATE GORY
APPLICATION NUMBE R OR MONOGRAPH CITATION
MARKE TING START DATE
MARKE TING END DATE
unappro ved drug o ther
11/30 /20 15
LABELER -
South Coast Specialty Compounding, Inc. d/b/a Park Compounding
(069419104)
Revised: 11/2015